Immunohistochemical and western blot analyses showed that the expressions of fibrosis markers, fibronectin and α-SMA, were significantly increased at 14 days after AKI, while all these changes were aggravated in EP4 inhibitor-treated IRI mice (Figures 2F,G). The gene discussed is FN1; the disease is acute kidney injury.